How Joyner was paid
$21.2M in total for 2025, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.
Named executive officers
| Executive | Salary | Stock | Options | Incentive | Pension | Other | Total |
|---|---|---|---|---|---|---|---|
| J. David JoynerPresident and Chief Executive Officer | $1,500,000 | $14,499,931 | $0 | $4,695,900 | $64,644 | $453,609 | $21,214,084 |
| Brian O. NewmanExecutive Vice President and Chief Financial Officer | $696,970 | $5,599,950 | $1,399,989 | $1,562,000 | — | $161,599 | $9,420,508 |
| Tilak MandadiExecutive Vice President, Ventures and Chief Experience and Technology Officer | $1,000,000 | $5,599,965 | $1,399,996 | $2,561,000 | — | $416,755 | $10,977,716 |
| Steven H. NelsonExecutive Vice President and President, Aetna | $1,000,000 | $5,799,915 | $1,449,994 | $2,988,000 | — | $349,201 | $11,587,110 |
| Prem S. ShahExecutive Vice President and Group President | $1,100,000 | $7,199,920 | $1,799,993 | $3,013,000 | — | $266,297 | $13,379,210 |
| Thomas F. CowheyFormer Executive Vice President and Chief Financial Officer | $420,833 | $4,399,978 | $1,099,995 | $0 | $3,097 | $791,235 | $6,715,138 |
What changed and why
- $402.1BCVS Health delivered $402.1 billion in revenue and generated $10.6 billion in operating cash flow during fiscal 2025.
- $21.2MJ. David Joyner received total compensation of $21,214,084 for fiscal year 2025 in his role as President and CEO.
- 59%The Management Planning and Development Committee actively engaged with stockholders following a 59% say-on-pay approval vote in 2025.
- Brian O. Newman joined the Company as Executive Vice President and Chief Financial Officer on April 21, 2025.
- $583KThomas F. Cowhey stepped down as CFO and later terminated employment without cause, receiving $583,333 in separation payments.
About this page
Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.